← All companies

HRTX

Heron Therapeutics, Inc.

HRTX Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.51

+0.01 +2.28%

Key statistics

from XBRL data in SEC filings

Market cap

$96.8M

Revenue (TTM)

$151M

Net income (TTM)

-$30.7M

EPS (TTM)

$-0.17

P/E ratio

—

Dividend yield

—

Free cash flow

-$27.9M

Cash

$26.1M

Total assets

$246M

Gross margin

71.1%

52-week range

$0.38 – $1.88

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Delisting notice or listing-rule failure Jun 25, 2026 8-K Shareholder vote results Jun 16, 2026 8-K Other events Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Director or officer change Apr 6, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure Jan 9, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Director or officer change; Regulation FD disclosure Oct 29, 2025 8-K Shareholder vote results Oct 15, 2025 8-K Entered a material agreement Aug 28, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Other events Aug 15, 2025 8-K Entered a material agreement; Amended charter or bylaws; Other events Aug 12, 2025 8-K Entered a material agreement Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Other events Aug 8, 2025 8-K Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Other events May 6, 2025 8-K Director or officer change Apr 29, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Entered a material agreement Feb 20, 2025 8-K Regulation FD disclosure Dec 23, 2024 8-K Other events Dec 3, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change; Regulation FD disclosure Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Regulation FD disclosure Jul 2, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 18, 2024 8-K Regulation FD disclosure May 29, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Director or officer change Mar 21, 2024